Maria Dall'Era, MD

Professor of Medicine

Maria Dall’Era is the Jean S. Engleman Distinguished Professor of Medicine and Chief of the Division of Rheumatology at the University of California, San Francisco (UCSF).

She is Director of the UCSF Rheumatology Clinical Research Center and Lupus Clinic. She also serves as the Chair of the Lupus Clinical Investigators Network (LuCIN) and is a steering committee member of the Lupus Academy, Lupus Forum, and the Lupus 21st Century annual conference. She is the PI of a CDC-funded population- based longitudinal lupus cohort in the San Francisco Bay Area called the California Lupus Epidemiology Study and the PI on clinical trials focused on SLE and lupus nephritis.

She completed her Medical Degree in 1997, from the University of California, San Francisco, where she later completed her Internship and Residency, and became Chief Resident and the Fellow. She has authored numerous publications in the areas of SLE and lupus nephritis. She is a co-author of the Treatment of Lupus Nephritis chapter in Up-To-Date. She received the Edmund L. Dubois Memorial Lectureship Award from the American College of Rheumatology and the Evelyn V. Hess award from the Lupus Foundation of America.

Her research interests include systemic lupus erythematosus, lupus nephritis, novel biologic agents, lupus nephritis outcomes, and clinical trials.

Education
2004 - Fellowship in Rheumatology, University of California, San Francisco
M.D., 1997 - School of Medicine, University of California, San Francisco
BA, 1993 - Immunology, University of California, Berkeley
Residency, - School of Medicine, University of California, San Francisco
Honors and Awards
  • Evelyn V. Hess Award, Lupus Foundation of America, 2023
  • Edmund L. Dubois Memorial Lectureship Award, American College of Rheumatology, 2018
  • Purple Ribbon Award, Lupus Foundation of America, 2014
  • Exceptional Physician Award, UCSF, 2010
  • Ira M. Goldstein Award for Outstanding Teaching in Rheumatology, UCSF, 2007
  • Ephraim Engleman Award for Excellence in Arthritis Research, UCSF, 2006
Websites
Publications
  1. Dall'Era M, Bruce IN, Gordon C, Manzi S, McCaffrey J, Lipsky PE. Current challenges in the development of new treatments for lupus. Annals of the rheumatic diseases 2019. PMID: 30636212


  2. Dall'Era M. Mycophenolate mofetil in the treatment of systemic lupus erythematosus. Current opinion in rheumatology 2011. PMID: 21720247


  3. Dall'era M, Chakravarty EF. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies. Current rheumatology reports 2011. PMID: 21584692


  4. Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide. Volume 63 of Issue 3. Arthritis care & research 2010. PMID: 21080348


  5. Dall'Era M, Chakravarty E, Wallace D, Genovese M, Weisman M, Kavanaugh A, Kalunian K, Dhar P, Vincent E, Pena-Rossi C, Wofsy D. Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial. Volume 56 of Issue 12. Arthritis and rheumatism 2007. PMID: 18050206